The previously identified quality defect was the placement of an incorrect active substance name on the unit packaging of the medicinal product Clopidogrel Genoptim. Potential effects: incorrect use of the medicine, lack of treatment efficacy, possible treatment complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Patients may use the product from the listed batches according to their doctor’s recommendations; if there are any doubts about the packaging, consult a pharmacist or doctor.
The decision to withdraw batches 1808325, 1808326, 1808327 of Clopidogrel Genoptim from the market was fully revoked after submission of documentation confirming correct repackaging and storage.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related